FDA Approved: COARTEM — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved COARTEM, a fixed-dose combination of artemether and lumefantrine, under an Original Application by Novartis for the treatment of uncomplicated mala…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Coartem (artemether-lumefantrine)

Snippet

ORIG AP for COARTEM (ARTEMETHER AND LUMEFANTRINE)